BDN - information sheet

Nickel, bis[1-[4-(dimethylamino)phenyl]-2-phenyl-1,2-ethenedithiolato(2-)-S,S']-
CAS Registry Number 38465-55-3

Publications summarized:

The Government of Canada conducts risk assessments of substances under the Canadian Environmental Protection Act, 1999 (CEPA 1999) to determine whether they present or may present a risk to human health or to the environment.
- The risks posed by a substance are determined by both its hazardous properties (potential to cause adverse human health or ecological effects) and the amount or extent of exposure to people and the environment.
- When needed, the Government implements risk management measures under CEPA 1999 and other federal acts to help prevent or reduce potential harm.
The Government concluded that BDN is not harmful to human health or to the environment at levels of exposure considered in the assessment.

The screening assessment concluded on the substance BDN. This substance was assessed as part of Batch 9 of the Challenge initiative of the CMP.
According to information gathered by the Government at the time of the assessment, BDN was not in commerce in sufficient quantities to be reported.

Given the low commercial activity, it was determined that likelihood of exposure of Canadians and the environment to BDN is low. Other sources of entry into the environment were not identified at the time of the assessment.

On the basis of classifications by international and national agencies, BDN was not identified as posing a high hazard to human health for carcinogenicity, genotoxicity, developmental or reproductive toxicity.
BDN is considered to be highly hazardous to non-human organisms.

Based upon information presented in the screening assessment, the risk to human health and to the environment from BDN was considered to be low.

The Government concluded that BDN is not harmful to human health and that this substance is not entering the environment at levels that are harmful.

Although BDN was not considered to be harmful to the environment at the time of the assessment, it is associated with ecological effects of concern. There may be a potential risk if exposure to BDN were to increase or use patterns were to change.
BDN is subject to the Significant New Activity (SNAc) provisions of CEPA 1999. This requires that the Government be notified of certain proposed new activities related to this substance, and that the new activity be assessed for potential risks to human health and the environment before being undertaken.
The order outlines the definition of a significant new activity in relation to BDN, as well as the information that needs to be provided to the Government for assessment before the new activity is undertaken.

Updates on actions for BDN can be found on the timeline for substances in Batch 9 of the Challenge initiative.
Information on SNAc provisions applied to substances, where applicable, is found in the SNAc publications dataset.
Additional information on the risk management of substances addressed under the CMP is available.
Use the Substances Search tool to find substances that are referenced in certain legislative or regulatory instruments or on Government of Canada websites.

The screening assessment focused on potential risks from exposure of the general population of Canada, rather than occupational exposure. Hazards related to chemicals used in the workplace are defined within the Workplace Hazardous Materials Information System (WHMIS). For information concerning workplace health and safety and what steps to take in the workplace, Canadians should consult their employer and/or the Occupational Health and Safety Regulator in their jurisdiction.